Medicine passport
EXJADE 250 mg
The same active substance, strength and form as listed by each country’s medicines regulator. For showing a pharmacist abroad.
- Active substance
- Deferasirox
- Strength
- 250 mg
- Form
- tablet for suspension
- ATC code
- V03AC03
- Registered in
- Canada · Novartis Pharmaceuticals Canada Inc
- Prescription
- Prescription only
- DIN
- 02287439
Source: Drug Product Database · 2026-09-30
Not a prescription. Not a statement that these products are interchangeable. Products are matched on active substance, strength and kind of form only. Other ingredients, release, approved uses and the dose on the box can differ. A pharmacist or doctor decides whether one can replace another.
Listed in other countries
United States 12 matching products
| Name on the box | Strength and form | Prescription | Holder | Official record |
|---|---|---|---|---|
| Deferasirox | 250 mg · Tablet, for Suspension | Prescription only | Teva Pharmaceuticals, Inc. (+10) | 0480-7012 |
| Exjade | 250 mg · Tablet, for Suspension | Prescription only | Novartis Pharmaceuticals Corporation | 0078-0469 |
Source: NDC Directory (US Food and Drug Administration) · 2026-09-13 · Source: US Food and Drug Administration, NDC Directory.
Same active substance, but no match for this strength and form
- Bulgaria: 8 products · Every strength and form
- European Union: 3 products · Every strength and form
- Spain: 42 products · Every strength and form
- Netherlands: 69 products · Every strength and form
- Switzerland: 19 products · Every strength and form